Literature DB >> 19536080

The cell cycle and acute kidney injury.

Peter M Price1, Robert L Safirstein, Judit Megyesi.   

Abstract

Acute kidney injury (AKI) activates pathways of cell death and cell proliferation. Although seemingly discrete and unrelated mechanisms, these pathways can now be shown to be connected and even to be controlled by similar pathways. The dependence of the severity of renal-cell injury on cell cycle pathways can be used to control and perhaps to prevent acute kidney injury. This review is written to address the correlation between cellular life and death in kidney tubules, especially in acute kidney injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19536080      PMCID: PMC2782725          DOI: 10.1038/ki.2009.224

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  116 in total

Review 1.  Checkpoints: controls that ensure the order of cell cycle events.

Authors:  L H Hartwell; T A Weinert
Journal:  Science       Date:  1989-11-03       Impact factor: 47.728

2.  Expression of two "immediate early" genes, Egr-1 and c-fos, in response to renal ischemia and during compensatory renal hypertrophy in mice.

Authors:  A J Ouellette; R A Malt; V P Sukhatme; J V Bonventre
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

3.  D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA.

Authors:  Y Xiong; H Zhang; D Beach
Journal:  Cell       Date:  1992-10-30       Impact factor: 41.582

4.  Changes in gene expression after temporary renal ischemia.

Authors:  R Safirstein; P M Price; S J Saggi; R C Harris
Journal:  Kidney Int       Date:  1990-06       Impact factor: 10.612

5.  Participation of p53 protein in the cellular response to DNA damage.

Authors:  M B Kastan; O Onyekwere; D Sidransky; B Vogelstein; R W Craig
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

6.  Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2.

Authors:  M G Lee; P Nurse
Journal:  Nature       Date:  1987 May 7-13       Impact factor: 49.962

7.  Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta.

Authors:  A Koff; M Ohtsuki; K Polyak; J M Roberts; J Massagué
Journal:  Science       Date:  1993-04-23       Impact factor: 47.728

8.  Phosphorylation independent activation of human cyclin-dependent kinase 2 by cyclin A in vitro.

Authors:  L Connell-Crowley; M J Solomon; N Wei; J W Harper
Journal:  Mol Biol Cell       Date:  1993-01       Impact factor: 4.138

9.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

Authors:  J W Harper; G R Adami; N Wei; K Keyomarsi; S J Elledge
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

10.  The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme.

Authors:  J Yuan; S Shaham; S Ledoux; H M Ellis; H R Horvitz
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

View more
  94 in total

1.  INK4a deletion results in improved kidney regeneration and decreased capillary rarefaction after ischemia-reperfusion injury.

Authors:  David H Lee; Jesse M Wolstein; Basu Pudasaini; Matthew Plotkin
Journal:  Am J Physiol Renal Physiol       Date:  2011-09-28

Review 2.  Targeting Endogenous Repair Pathways after AKI.

Authors:  Benjamin D Humphreys; Vincenzo Cantaluppi; Didier Portilla; Kai Singbartl; Li Yang; Mitchell H Rosner; John A Kellum; Claudio Ronco
Journal:  J Am Soc Nephrol       Date:  2015-11-18       Impact factor: 10.121

3.  Renal-targeting triptolide-glucosamine conjugate exhibits lower toxicity and superior efficacy in attenuation of ischemia/reperfusion renal injury in rats.

Authors:  Yu Fu; Qing Lin; Tao Gong; Xun Sun; Zhi-Rong Zhang
Journal:  Acta Pharmacol Sin       Date:  2016-07-11       Impact factor: 6.150

4.  hMSH2 recruits ATR to DNA damage sites for activation during DNA damage-induced apoptosis.

Authors:  Navjotsingh Pabla; Zhengwei Ma; Michael A McIlhatton; Richard Fishel; Zheng Dong
Journal:  J Biol Chem       Date:  2011-02-01       Impact factor: 5.157

5.  Overexpression of p18INK⁴C in LLC-PK1 cells increases resistance to cisplatin-induced apoptosis.

Authors:  Yi Zhang; Li Yuan; Lili Fu; Chunyan Liu; Dongmei Liu; Changlin Mei
Journal:  Pediatr Nephrol       Date:  2011-04-15       Impact factor: 3.714

Review 6.  microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles.

Authors:  Kirti Bhatt; Qing-Sheng Mi; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-12

7.  Mitigation of acute kidney injury by cell-cycle inhibitors that suppress both CDK4/6 and OCT2 functions.

Authors:  Navjotsingh Pabla; Alice A Gibson; Mike Buege; Su Sien Ong; Lie Li; Shuiying Hu; Guoqing Du; Jason A Sprowl; Aksana Vasilyeva; Laura J Janke; Eberhard Schlatter; Taosheng Chen; Giuliano Ciarimboli; Alex Sparreboom
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

Review 8.  Regulation of TFEB activity and its potential as a therapeutic target against kidney diseases.

Authors:  Weihuang Zhang; Xiaoyu Li; Shujun Wang; Yanse Chen; Huafeng Liu
Journal:  Cell Death Discov       Date:  2020-05-01

9.  A Pharmacologic "Stress Test" for Assessing Select Antioxidant Defenses in Patients with CKD.

Authors:  Richard A Zager; Ali C M Johnson; Alvaro Guillem; Jeff Keyser; Bhupinder Singh
Journal:  Clin J Am Soc Nephrol       Date:  2020-04-14       Impact factor: 8.237

10.  Bromate-induced Changes in p21 DNA Methylation and Histone Acetylation in Renal Cells.

Authors:  Ramya T Kolli; Travis C Glenn; Bradley T Brown; Sukhneeraj P Kaur; Lillie M Barnett; Lawrence H Lash; Brian S Cummings
Journal:  Toxicol Sci       Date:  2019-04-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.